Kalgene Pharmaceuticals Inc.

$350,000.00 CAD

≈ 5 Canadians' average pay for a year
Department
National Research Council Canada
Program
Industrial Research Assistance Program – Contributions to Firms
Recipient country
Canada
Fiscal year
2017-2018
Agreement period
January 2, 2018 – March 31, 2019
Reference
nrc-cnrc:172-2018-2019-Q3-899107

Published purpose

KalGene and its NRC partners have identified a novel biological agent against amyloid-beta for Alzheimer’s disease. The IRAP project will support the late-stage development of the drug candidate..

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions